An asymptomatic 37-year-old woman with good oral hygiene received plain radiographs ( Figure 1 ) as part of a wisdom teeth extraction preoperative work-up. Unenhanced computed tomography (CT) with multiplanar and 3-dimensional reformations (Figures 2 and 3 ) was performed to follow up the findings on radiography.
. (A) Waters/occipitomental view. Enlargement of the left greater wing of the sphenoid, zygomatic arch, and facial asymmetry (white arrows). Diminutive maxillary sinus (arrowheads). Mandibular findings are seen faintly (black arrows). (B) Pantomograph. Expansile lytic lesion centered in the left mandibular angle without associated periosteal reaction or cortical breakthrough (black arrows). Left sphenoid expansion (arrowheads) is also seen. There is superior displacement of the inferior alveolar canal in the left mandible (grey arrows).
Diagnosis
Leontiasis ossea (polyostotic facial fibrous dysplasia).
Radiologic Findings
Radiographs and CT images demonstrate the expansile nature of the process involving the facial bones and mandible. There is narrowing of the vidian canal and foramen rotundum. There is no evidence of soft tissue mass, periosteal reaction, or cortical breakthrough.
Discussion
Fibrous dysplasia (FD) is a genetic, noninherited benign bone lesion. It can present at any age, but usually is detected by the third decade of life [1] . FD constitutes 5% to 7% of benign bone tumours and has no sex predilection [1] .
FD may occur in several forms. Monostotic FD is the most common form and affects a single bone, usually the ribs, femur, tibia, cranium, maxilla, or mandible. Monostotic lesions enlarge in proportion to skeletal growth [1] . Polyostotic FD involves several sites, usually is isolated to one side of the body, and often involves facial bones. Lesions of polyostotic FD often continue to enlarge after skeletal maturity is achieved [1] . Leontiasis ossea is the term given to FD with maxillary involvement that results in a progressive protrusion of the malar surface and loss of the nasomaxillary angle, resulting in a leonine facial appearance [2] . Another form of FD occurs as part of the classic triad of the McCune-Albright syndrome: FD with precocious puberty and caféau-lait cutaneous pigment changes [1] . Mazabraud syndrome is the combination of FD and intramuscular myxomas [1] .
On a molecular level, FD is the result of an amino acid substitution mutation of cysteine or histidine for arginine at position 210 in chromosome 20 [1] . This substitution mutation in some somatic cells results in increased intracellular messengers that stimulate cellular proliferation and inappropriate differentiation [1] . Subsequent abnormal development and mineralization of bone can result in loss of strength in the affected bone [1] .
Clinically, affected individuals may have variable presentations, depending on the location of the lesion. Patients with craniofacial FD may be asymptomatic or present with bony or neuropathic pain, swelling or deformity, or cranial neuropathies [1, 3, 4] .
FD often first is identified on plain radiographs. Its appearance usually is described as ground-glass and it may have one or a combination of the following patterns: pagetoid, sclerotic, and cystic [1, 4] . There is no visible trabecular pattern. Lesions increase the diameter of the involved bone, with a smooth periosteum and a scalloped endosteal margin. Other features include reactive bone formation and loss of distinction between the cortex and medulla. Uncomplicated FD lesions typically look nonaggressive [5] .
Craniofacial FD usually is unilateral, but may cross suture lines. It expands the diploic space and displaces the outer table, sparing the inner table. The main radiographic diagnostic considerations for craniofacial FD are neo-osteogenesis near a site of surgery or chronic inflammation, ossifying fibroma, osteoma [6] , or Paget's disease [1] . Other lesions that may present clinically as slowly progressive swelling in the face are neurofibromas, hemangiomas, and lymphatic or vascular malformations [2] . Cherubism shows bilateral maxillary and/or mandibular expansion, but is histologically separate from fibrous dysplasia [7] .
CT in craniofacial FD exquisitely shows the classic ground-glass matrix and bone expansion with intact cortex, and also can show potential complications such as optic nerve compression and neural foraminal stenosis. Multiplanar reformation may be useful to assess neural foraminal involvement. As in this case, 3-dimensional reformations can be used to illustrate the bony expansion and overall appearance. If iodinated contrast is given, variable enhancement of the fibrous component may be seen [6] .
Magnetic resonance imaging may be helpful in the evaluation of a FD lesion, particularly in the assessment of adjacent soft tissue in craniofacial lesions. However, given the variable composition of FD lesions, signal intensity can vary [8] . On T1, FD has low or intermediate signal owing to the mineralized stroma, high fibrous tissue content, and low water content [1, 5] . The mineralized component also provides low T2 signal and the metabolically active fibrous components and cystic spaces yield high T2 signal intensity. Therefore, lesions on T2-weighted images may have a range of appearances depending on the ratio of mineralized to fibrous material in the lesion. The enhancement can be variable, with the fibrous component often enhancing intensely [6] . Small central vessels and larger peripheral sinusoids account for the enhancement of these lesions [5, 8] . Unfortunately, the magnetic resonance image appearance is nonspecific because intermediate T1 intensity and high T2 intensity are features common to both fibrous dysplasia and sinister entities including malignancy [5] .
Nuclear medicine scintigraphic imaging is important in the initial work-up of a patient with suspected FD to rule out polyostotic disease. By using technetium-99m, FD lesions may show increased, minimal, or no uptake, depending on the metabolic activity of the lesion [9] . On a 3-phase scan, the uptake is most pronounced in the delayed phase [9] . In addition to Tc-99 m methylene diphosphonate (MDP) uptake, FD lesions have been found to show gallium-67 uptake [10] .
Complications of fibrous dysplasia depend on the location of the lesion. Bony pain, deformities, and pathologic or fatigue fractures may involve any bone. Involvement of the cranium and facial bones can produce a wide range of complications including headaches, anosmia, deafness, visual loss, diplopia, recurrent otitis, malocclusion, and trigeminal neuralgia. Lesions may hemorrhage spontaneously or result in sinus obstruction and mucocele formation [11, 12] . Nearly half of patients with FD of the temporal bone develop external ear canal cholesteatoma [4] .
A rare but serious complication of FD is malignant transformation. The rate of malignant transformation is quoted as between less than 1% and 5% in the literature [3, 13] . A history of radiotherapy may be associated with malignant degeneration [3] . Clinical findings that suggest the possibility of malignant transformation include a rapid increase in pain and size of a lesion, intralesional necrosis, bleeding, and increased serum alkaline phosphatase level [3] . The most common malignancies are osteosarcoma, fibrosarcoma, and chondrosarcoma [13] .
If a case of FD is noted incidentally on an imaging study, it usually is suggested that the patient undergo a bone scan to rule out polyostotic disease. Instead of proceeding to biopsy, it is suggested that the patient undergo follow-up evaluation and observation every 6 months for an unspecified amount of time [1] . Ophthalmic and cranial nerve examinations are necessary to detect neurologic deficits early in FD of the craniofacial bones. Ippolito et al [14] suggested that patients with FD undergo endocrinologic evaluation to optimize medical management. If the diagnosis is unsure, a test of peripheral blood may allow detection of the genetic mutation associated with fibrous dysplasia.
If surgery is deemed necessary, it has been suggested that it be delayed until skeletal maturity is reached because of the risk of recurrence with subsequent growth [1] . Simple curettage and osteotomies show recurrence and heal with dysplastic bone [1] . Reconstruction with autologous cancellous bone graft may be successful in some cases [1] . The utility of bisphosphonate therapy in fibrous dysplasia has been studied with early reports suggesting possible benefits of pain control, decreased bone turnover, and improved radiologic appearance [15] .
There is controversy regarding treatment of craniofacial FD. Vision loss, one of the most serious complications of craniofacial FD, can progress rapidly and become irreversible. It has been hypothesized that this vision loss is secondary to invasion of the optic canal by dysplastic bone. Some groups advocate prophylactic decompression of the optic nerve, based on CT findings of encroachment of the optic canal [3] . However, in a retrospective review, Michael et al [16] found that visual loss in 20 cases of FD may not have been prevented by prophylactic optic canal decompression, leading the investigators to offer alternate theories of visual loss including displacement or distortion of the globe with traction on the optic nerve, external compression by a cystic lesion, and vascular events.
Although craniofacial FD is typically a benign disease, it can have serious complications, predominantly relating to regional mass effect and nerve compression. Knowledge of this entity and its typical appearance can facilitate early diagnosis. Beyond diagnosis, close radiologic evaluation for potential complications from mass effect may be able to help direct treatment.
